Russell Investments Group’s X4 Pharmaceuticals XFOR Stock Holding History

Russell Investments Group’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.01K	Hold	729	–	–	﹤0.01%	3963
2025 Q4	$2.92K	Hold	729	–	–	﹤0.01%	3973
2025 Q3	$2.49K	Sell	729 -8,998	-93%	-$23.2K	﹤0.01%	3982
2025 Q2	$18.5K	Buy	+9,727	New	+$39.8K	﹤0.01%	3209
2024 Q3	–	Sell	-63	Closed	-$1.1K	–	3810
2024 Q2	$1.1K	Buy	+63	New	+$2.06K	﹤0.01%	3422
2021 Q2	–	Sell	-226	Closed	-$58K	–	3303
2021 Q1	$58K	Hold	226	–	–	﹤0.01%	3025
2020 Q4	$43K	Sell	226 -671	-75%	-$132K	﹤0.01%	2939
2020 Q3	$182K	Buy	+897	New	+$215K	﹤0.01%	2805
2019 Q4	–	Sell	-350	Closed	-$133K	–	3144
2019 Q3	$133K	Buy	+350	New	+$139K	﹤0.01%	2757

Other funds holding XFOR

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Russell Investments Group's XFOR Position: Q1 2026 in Review

Russell Investments Group held its X4 Pharmaceuticals (XFOR) position steady in Q1 2026 at 729 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #3963.

Russell Investments Group first reported a position in XFOR in Q3 2019 and has held it in 9 quarters since. The position peaked at $182K in Q3 2020. 84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

Russell Investments Group held 729 shares of X4 Pharmaceuticals worth $3.01K as of Q1 2026.
Russell Investments Group left its X4 Pharmaceuticals share count unchanged in Q1 2026.
X4 Pharmaceuticals made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3963 holding.
Russell Investments Group first reported a position in X4 Pharmaceuticals in Q3 2019 and has held it in 9 quarters since.
Russell Investments Group's X4 Pharmaceuticals position peaked at $182K in Q3 2020.
84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.